Recall Register

Drug recall: INFed (Iron Dextran Injection USP) 100 mg elemental iron/2 mL (50 mg/mL), Rx only, packaged in 2 mL Sterile Single…

Class II FDA enforcement event 81535. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Failed Stability Specification: out of specification for iron content.

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

ALLERGAN started this drug recall on 8 Nov 2018. The firm address in the FDA record is in Madison, NJ. FDA put the recall in Class II. FDA event 81535 has 1 product record. The first FDA enforcement report date is 5 Dec 2018. The record gives the status Terminated, with the termination date 6 Apr 2020.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Product was distributed throughout the United States.

Recalling firm

ALLERGAN, Madison, NJ.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 81535: product records
Recall numberProductQuantityClassStatusReport date
D-0282-2019INFed (Iron Dextran Injection USP) 100 mg elemental iron/2 mL (50 mg/mL), Rx only, packaged in 2 mL Sterile Single Dose Vial, Mfd by Patheon Italia S.p.A. Ferentino, Italy NDC 52544-931-07111,132 cartons/10 vials per cartonClass IITerminated5 Dec 2018

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Drug events that started in 2018
367
Share of these events in Class II
60%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
4

Other events of the firm

Official channels

Cite this page

Recall Register. FDA enforcement event 81535. https://recallregister.com/fda/ii/81535/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Product was distributed throughout the United States.
What quantity of product is in FDA event 81535?
The FDA record gives this quantity: 111,132 cartons/10 vials per carton
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2018 have the same class?
60% of the 367 drug events that started in 2018 are in Class II.